Taken together, results from the ~7-day deletion model demonstrate a predominant physiologic role for Nrf1 in counteracting liver inflammation, whereas results from the ~7-week deletion model suggest Nrf1 counteracts MASH progression to HCC, possibly via influencing pro-tumorigenic actions of Nrf2. Here, NFE2L2 is linked to hepatocellular carcinoma.